share_log

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga ·  Feb 7 01:31

Gainers

  • InVivo Therapeutics Hldg (NASDAQ:NVIV) stock rose 306.0% to $0.9 during Tuesday's regular session. The company's market cap stands at $2.7 million.
  • Cyclerion Therapeutics (NASDAQ:CYCN) stock rose 56.02% to $4.4. The company's market cap stands at $10.7 million.
  • Tenax Therapeutics (NASDAQ:TENX) stock increased by 41.62% to $12.35. The market value of their outstanding shares is at $3.6 million.
  • Equillium (NASDAQ:EQ) stock increased by 35.62% to $1.08. The company's market cap stands at $38.1 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock moved upwards by 31.11% to $1.77. The market value of their outstanding shares is at $202.7 million.
  • Immunome (NASDAQ:IMNM) stock increased by 26.06% to $21.28. The company's market cap stands at $958.2 million.

Losers

  • BioRestorative Therapies (NASDAQ:BRTX) stock decreased by 57.1% to $1.48 during Tuesday's regular session. The market value of their outstanding shares is at $6.9 million.
  • Akso Health Group (NASDAQ:AHG) stock fell 26.13% to $1.65. The company's market cap stands at $176.7 million.
  • Sagimet Biosciences (NASDAQ:SGMT) stock decreased by 25.99% to $6.75. The market value of their outstanding shares is at $215.2 million.
  • Biolase (NASDAQ:BIOL) stock fell 23.79% to $0.53. The company's market cap stands at $1.8 million.
  • NanoString Technologies (NASDAQ:NSTG) stock declined by 19.05% to $0.08. The company's market cap stands at $4.0 million.
  • Apollomics (NASDAQ:APLM) shares declined by 18.93% to $0.59. The market value of their outstanding shares is at $52.8 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment